Shalini Sharp
2012 - Ultragenyx Pharmaceutical
In 2012, Shalini Sharp earned a total compensation of $303.5K as Chief Financial Officer and Senior Vice President at Ultragenyx Pharmaceutical.
Compensation breakdown
| Non-Equity Incentive Plan | $51,560 |
|---|---|
| Option Awards | $90,042 |
| Salary | $148,669 |
| Other | $13,228 |
| Total | $303,499 |
Sharp received $148.7K in salary, accounting for 49% of the total pay in 2012.
Sharp also received $51.6K in non-equity incentive plan, $90K in option awards and $13.2K in other compensation.
Rankings
In 2012, Shalini Sharp's compensation ranked 10,104th out of 11,487 executives tracked by ExecPay. In other words, Sharp earned more than 12.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,104 out of 11,487 | 12th |
Division Manufacturing | 3,748 out of 4,253 | 12th |
Major group Chemicals And Allied Products | 1,043 out of 1,198 | 13th |
Industry group Drugs | 796 out of 920 | 14th |
Industry Pharmaceutical Preparations | 607 out of 700 | 13th |
Source: SEC filing on May 23, 2014.
Sharp's colleagues
We found two more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2012.